Plant Pathology (Scientist)
AAO appeal decision on the EB-1A talent visa
Updated: Author: Alina Kanametova
This is a real, anonymized AAO appeal decision on the EB-1A immigrant visa, in the field of Plant Pathology (Scientist) (Science), 2024. The appeal was case remanded, and on the final-merits determination the petitioner did not clearly meet the standard. Of the regulatory criteria, 2 were counted: Judging, Scholarly authorship; not counted: Published material about you, Leading role.
What this case shows
Bottom line: the case went back to the officer for another look, not a final decision. Of the 4 EB-1A criteria claimed, 2 were counted. It never reached the final-merits stage: that requires at least 3 counted criteria.
EB-1A criteria in this case
- Awardsnot claimed
- Membershipnot claimed
- Published material about younot counted
- Judgingcounted
- Original contributionnot claimed
- Scholarly authorshipcounted
- Exhibitionsnot claimed
- Leading rolenot counted
- High remunerationnot claimed
- Commercial successnot claimed
- Comparable evidencenot claimed
Why these criteria usually go uncounted
The through-line of the appeals base: in 81% of decisions the AAO names the same problem - assertions not backed by sufficient evidence - and 45% of cases are lost at the final-merits totality assessment. Below is how each criterion not counted here fares across the whole base.
Published material about you
Across the appeals base this criterion was argued in 793 cases and counted in 286 (36%). Typical AAO objections: "Outlet not shown to be major media"; "Published material not ABOUT the person". Counts coverage specifically ABOUT YOU in independent major or trade outlets, with publication details.
Leading role
Across the appeals base this criterion was argued in 624 cases and counted in 256 (41%). Counted when the organization is known and the role is leading or key, per the org chart and letters.
The Science field in the database: 155 appeals
Outcomes in this field: 7 sustained, 30 remanded, 118 dismissed. How the AAO ruled in this field on the criteria argued in this case:
| Criterion | In this case | Counted in the field | How objections were answered |
|---|---|---|---|
| Published material about you | not counted | 35 of 89 (39%) | breakdowns for this criterion (7) |
| Judging | counted | 105 of 117 (90%) | breakdowns for this criterion (7) |
| Scholarly authorship | counted | 121 of 127 (95%) | breakdowns for this criterion (6) |
| Leading role | not counted | 19 of 54 (35%) | breakdowns for this criterion (7) |
Counted over our base of published AAO decisions; all Science appeals.
From the AAO decision (source, EN)
The initial denial was due to the petitioner not meeting at least three of the ten initial evidentiary criteria. The AAO found the petitioner met the criteria for judging and scholarly articles, but not for published material or leading/critical roles. The determination regarding 'original contributions' was remanded back to the director for further review and a more detailed explanation of the reasoning.
The quote summarizes a fragment of the decision; the table above reflects the FINAL status of the criteria across all stages of the case (including ones conceded before the appeal), so the wording may not match one-to-one.
Full AAO decision of October 2, 2024 (PDF, uscis.gov)AAO decisions archive on uscis.gov
FAQ on this case
- Which EB-1A criteria were counted in this case?
- Criteria claimed: 4, counted: 2 (Judging, Scholarly authorship); not counted: Published material about you, Leading role.
- How did this appeal end?
- The case was remanded: the AAO withdrew the decision and sent it back to the officer - not a final approval, but not a final denial either.
- Did the case reach the final-merits stage?
- No - the case did not reach final merits: fewer than the required 3 criteria were counted.
The criteria not counted here - typical objections and how to respond:
Related
Similar appeals
- Biomedical Sciences/Bone Healthappeal dismissed, 2021
- Biopharmaceutical Manufacturing (specifically SAP Planning Specialist)appeal dismissed, 2021
- biomedical scienceappeal dismissed, 2020
- Sciences (Rehabilitation Therapy/Art Therapy)appeal dismissed, 2024
- Chemistryappeal dismissed, 2024
- Plant Pathology Researchappeal dismissed, 2022
- Materials Chemistryappeal dismissed, 2020